WEGO
WEGO
Shandong Weigao Group Medical Polymer Products Co. and its subsidiaries are principally engaged in the research and development
Shandong Weigao Group Medical Polymer Products Co. and its subsidiaries are principally engaged in the research and development, manufacture and sale of disposable medical devices. We provide different kinds of products, including: i) consumables (infusion sets, syringes, medical needle products, blood bags, pre-filled syringes, blood collection products and other consumables used); ii) bone materials and iii) blood purification consumables and equipment. The Company is the industrialization base of the achievements of the National High Technology Research and Development (863) Program of China, a national high-tech enterprise and a national enterprise technology center. The main production base of the Group is located in Weihai City, Shandong Province, the PRC.
- All
- News
- Analysis
- Research
Briefing Jan 31, 2023 11:02 AM
· Healthcare
Fine Vision Completes Angel Financing Round Worth Nearly CNY 50 Mn
Briefing Jan 28, 2023 11:20 AM
· Healthcare
YingHe Neuro Raises Over CNY 100 Mn in Angel Round
In-depth
Briefing Jan 17, 2023 10:36 AM
· Healthcare
Medical Equipment Company PowerSite Nets Over CNY 100 Mn in Series B
Briefing Jan 13, 2023 11:03 AM
· Healthcare
Equipment Company Keyto Nets Over CNY 100 Mn in Series C
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 22, 2021 03:11 PM
Briefing Jan 12, 2023 10:53 AM
· Healthcare
IVD Company Bioantibody Nets Over CNY 100 Mn in Series A
Briefing Jan 12, 2023 10:25 AM
· Healthcare
Surgical Robot Platform Company KouTech Nets Over USD 10 Mn in Series A+ Round
Briefing Sep 09, 2022 04:12 PM
· Healthcare
Trulive Nets Hundreds of Mns of CNY in pre-Series B Financing Round
Briefing Sep 05, 2022 04:50 PM
· Healthcare
LinkZill Nets Tens of Millions of CNY in pre-Series A+
Healthcare
Dynamic Biosystems Snags Nearly CNY 100 Mn in Series A+
Dynamic Biosystems is a single cell and space multi-omics technology platform enterprise. The company focuses on exploring the huge potential in the fields of precision medicine of tumor, eugenics and fertility, and drug discovery, and is committed to promoting precision medicine to the era of single cell and space omics, helping life science and clinical medicine.
Yesterday 07:25 PM
In-depth
Healthcare
Tsingke Biotechnology: More Opportunities in the International Market of Gene Synthesis
‘Globalization is the only way to the development of the industry. It is more conducive to the rapid progress of the industry for domestic enterprises to compete with well-known overseas enterprises.’
Jan 30, 2023 02:13 PM
Briefing Aug 01, 2022 03:11 PM
· Healthcare
Biomedical Lab Supplies Producer Acumen Bags 100 Mn of CNY in Series A Round
Briefing Jun 24, 2022 11:15 AM
· Healthcare
F-star to be acquired by China biopharmaceutical with USD 161million
Briefing Jun 24, 2022 11:07 AM
· Healthcare
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
Insight
Briefing Jun 24, 2022 10:46 AM
· Healthcare
East China medicine "liraglutide" goes to sea
Briefing Jul 20, 2021 03:33 PM
· Technology
Ruiyuan Zhao Feng position announced in the second quarter, Xiaomi group is still the largest position stocks
See more
Related Companies
